Japanese tech major re-structures its teams for artificial intelligence-based drug development and strategies while expanding its presence in Europe. With confidence in the utility of AI for discovery, it is retaining a key focus on oncology while adding infectious diseases to its targets.

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights how Alife Health is using its AI-based platform for IVF to increase chances for successful pregnancies while Barnaby Pickering discusses how AI Medical Technology is using AI to detect melanoma. Reed Miller talks about weight-loss device maker Allurion Technologies’ signed SPAC deal.

Since its founding in 2019, Ronovo Surgical has designed and built a modular surgical robot that could rival the likes of Medtronic’s Hugo and CMR Surgical’s Versius.

One in eight couples in the US are struggling to get pregnant. Alife Health’s CEO Paxton Maeder-York believes that by leveraging artificial intelligence for use in IVF fertility clinics, he can help shape a future where more people have a better chance of starting families at a lower cost and higher rate of success.